To investigate the association of RUNX1T1 with patient outcome in primary neuroblastoma, Kaplan–Meier survival analysis was performed on a publicly available RNAseq dataset of 498 neuroblastoma samples. This evidence concerns the gene RUNX1T1 and neuroblastoma.